electroCore, Inc. (ECOR) is a Healthcare stock trading at $8.58 (as of 2026-06-18), with a market capitalization of $80.97M and a trailing P/E of -5.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
electroCore, Inc. develops and commercializes non-invasive vagus nerve stimulation therapies, including gammaCore, a prescription-only treatment for acute pain associated with migraine and episodic cluster headache in adults. Its primary product, gammaCore Sapphire, is a rechargeable, reloadable handheld device intended for regular or intermittent use.